Psychiatric medications: Adverse cutaneous drug reactions

被引:33
|
作者
Bliss, Sarah A. [1 ]
Warnock, Julia K. [1 ]
机构
[1] Univ Oklahoma, Dept Psychiat, Hlth Sci Ctr, Tulsa, OK 74135 USA
关键词
TOXIC EPIDERMAL NECROLYSIS; CARBAMAZEPINE HYPERSENSITIVITY SYNDROME; HAIR LOSS; SKIN PIGMENTATION; LAMOTRIGINE; PHOTOSENSITIVITY; FLUOXETINE; ERUPTION; IMIPRAMINE; ALOPECIA;
D O I
10.1016/j.clindermatol.2011.11.014
中图分类号
R75 [皮肤病学与性病学];
学科分类号
100206 ;
摘要
Psychiatric medications are among the most widely prescribed medications in the United States. Adverse cutaneous drug reactions are associated with psychiatric medications in approximately 2% to 5% of the individuals for whom they are prescribed. Although most adverse cutaneous drug reactions associated with psychotropic medications are benign and easily treated, some can be disfiguring or life-threatening, particularly those associated with the mood stabilizers. Adverse cutaneous drug reactions associated with antidepressants, antipsychotics, and mood stabilizers are reviewed, and important issues that are of concern for the dermatologist who must consider when and how to safely discontinue a psychotropic medication in their patients are presented. (C) 2013 Elsevier Inc. All rights reserved.
引用
收藏
页码:101 / 109
页数:9
相关论文
共 50 条
  • [31] Adverse drug reactions and related psychiatric disorders
    Carelli, R.
    Salvati, G.
    Di Sotto, A.
    Placidi, G. F.
    JOURNAL OF PSYCHOPATHOLOGY, 2008, 14 (01): : 16 - 22
  • [32] Adverse Drug Reactions in Hospitalized Psychiatric Patients
    Thomas, Michele
    Boggs, Angela A.
    DiPaula, Bethany
    Siddiqi, Shahida
    ANNALS OF PHARMACOTHERAPY, 2010, 44 (05) : 819 - 825
  • [33] Recognising severe cutaneous adverse drug reactions
    Chee, Paul
    MEDICAL JOURNAL OF AUSTRALIA, 2017, 207 (08) : 325 - +
  • [34] Guidelines of care for cutaneous adverse drug reactions
    Drake, LA
    Dinehart, SM
    Farmer, ER
    Goltz, RW
    Graham, GF
    Hordinsky, MK
    Lewis, CW
    Pariser, DM
    Skouge, JM
    Webster, SB
    Whitaker, DC
    Butler, B
    Lowery, BJ
    Bennin, B
    Apgar, JT
    Callen, JP
    McDonald, CJ
    JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY, 1996, 35 (03) : 458 - 461
  • [35] PHARMACOGENETICS OF CUTANEOUS ADVERSE DRUG-REACTIONS
    SHEAR, NH
    SPIELBERG, SP
    CLINICAL AND EXPERIMENTAL DERMATOLOGY, 1987, 12 (02) : 138 - 138
  • [36] Immunological Mechanisms in Cutaneous Adverse Drug Reactions
    Lee, Ai-Young
    BIOMOLECULES & THERAPEUTICS, 2024, 32 (01) : 1 - 12
  • [37] Cutaneous adverse drug reactions in hospitalised patients
    Lee, H. Y.
    Tay, L. K.
    Thirumoorthy, T.
    Pang, S. M.
    SINGAPORE MEDICAL JOURNAL, 2010, 51 (10) : 767 - 774
  • [38] CUTANEOUS ADVERSE DRUG REACTIONS IN ADULT PATIENTS
    Nezic, L.
    Celic, M.
    BASIC & CLINICAL PHARMACOLOGY & TOXICOLOGY, 2011, 109 : 82 - 82
  • [39] Cutaneous adverse drug reactions in childhood and adolescence
    Ott, H.
    MONATSSCHRIFT KINDERHEILKUNDE, 2011, 159 (11) : 1094 - +
  • [40] CUTANEOUS MANIFESTATIONS OF ADVERSE DRUG-REACTIONS
    LEVENSON, DE
    ARNDT, KA
    STERN, RS
    IMMUNOLOGY AND ALLERGY CLINICS OF NORTH AMERICA, 1991, 11 (03) : 493 - 507